{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:05:27Z","timestamp":1794639927340,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated the clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome (RA\/SS). Patients with RA\/SS in Peking Union Medical College Hospital from January 2012 to January 2017 were retrospectively analysed and compared to those of sex- and age\u2013matched RA or SS controls. Logistic regression analysis was used to identify risk factors. Altogether, 105 consecutive patients with RA\/SS were enrolled. Ninety-seven (92.4%) of them were female, with a mean age of 51.5\u2009\u00b1\u200913.3 years or 45.2\u2009\u00b1\u200914.7years at the diagnosis of SS or RA, respectively. In addition to arthritis and Sicca symptom, patients with RA\/SS had more visceral involvements including interstitial lung disease (ILD), and haematologic involvement, and received more glucocorticoid treatments than controls (p\u2009&lt;\u20090.05). RA-onset, simultaneous-onset and SS-onset patients had significant differences in age at RA diagnosis, fever and thrombocytopenia (p\u2009&lt;\u20090.05). Multivariate logistic analysis indicated that arthritis (OR\u2009=\u200944.804), rheumatoid factor (RF) (OR\u2009=\u20095.973), and anti-CCP (OR\u2009=\u20092.545) were independent risk factors for SS overlapping with RA. Xerostomia (OR\u2009=\u20093.960), ILD (OR\u2009=\u20096.210), and anti-SSA (OR\u2009=\u200924.640) were independent predictors of RA overlapping with SS. RA\/SS patients have more visceral involvements. Our findings highlight the roles of arthritis\/RF\/anti-CCP and xerostomia\/ILD\/anti-SSA in the development of this overlapping disease.<\/jats:p>","DOI":"10.1038\/s41598-018-24279-1","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T11:51:58Z","timestamp":1523533918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1038","volume":"8","author":[{"given":"Huaxia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8775-1699","authenticated-orcid":false,"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"24279_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61, 554\u2013558 (2002).","journal-title":"Ann Rheum Dis"},{"key":"24279_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13075-016-1173-0","volume":"18","author":"A Pecani","year":"2016","unstructured":"Pecani, A. et al. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Arthritis research & therapy 18, 276 (2016).","journal-title":"Arthritis research & therapy"},{"key":"24279_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","volume":"12","author":"A Saraux","year":"2016","unstructured":"Saraux, A., Pers, J. O. & Devauchelle-Pensec, V. Treatment of primary Sjogren syndrome. Nature reviews. Rheumatology 12, 456\u2013471 (2016).","journal-title":"Nature reviews. Rheumatology"},{"key":"24279_CR4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/rheumatology\/kes374","volume":"52","author":"J He","year":"2013","unstructured":"He, J. et al. Characteristics of Sjogren\u2019s syndrome in rheumatoid arthritis. Rheumatology 52, 1084\u20131089 (2013).","journal-title":"Rheumatology"},{"key":"24279_CR5","first-page":"448","volume":"54","author":"A Hajiabbasi","year":"2016","unstructured":"Hajiabbasi, A., Shenavar Masooleh, I., Alizadeh, Y., Banikarimi, A. S. & Ghavidel Parsa, P. Secondary Sjogren\u2019s Syndrome in 83 Patients With Rheumatoid Arthritis. Acta medica Iranica 54, 448\u2013453 (2016).","journal-title":"Acta medica Iranica"},{"key":"24279_CR6","first-page":"6669","volume":"34","author":"S Boussios","year":"2014","unstructured":"Boussios, S. et al. Cancer diagnosis in a cohort of patients with Sjogren\u2019s syndrome and rheumatoid arthritis: a single-center experience and review of the literature. Anticancer research 34, 6669\u20136676 (2014).","journal-title":"Anticancer research"},{"key":"24279_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1756-185X.2012.01717.x","volume":"15","author":"HJ Haga","year":"2012","unstructured":"Haga, H. J., Naderi, Y., Moreno, A. M. & Peen, E. A study of the prevalence of sicca symptoms and secondary Sjogren\u2019s syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile. International journal of rheumatic diseases 15, 284\u2013288 (2012).","journal-title":"International journal of rheumatic diseases"},{"key":"24279_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett, F. C. et al. The American Rheumatism Association1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315\u2013324 (1988).","journal-title":"Arthritis Rheum"},{"key":"24279_CR9","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/rheumatology\/kex320","volume":"56","author":"R Seror","year":"2017","unstructured":"Seror, R. & Mariette, X. Guidelines for treatment of primary Sjogren\u2019s syndrome: a first useful stone but still much to do. Rheumatology 56, 1641\u20131642 (2017).","journal-title":"Rheumatology"},{"key":"24279_CR10","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1097\/MD.0000000000000667","volume":"94","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Primary Sjogren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients. Medicine 94, e667 (2015).","journal-title":"Medicine"},{"key":"24279_CR11","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals, M. et al. Characterization of systemic disease in primary Sjogren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 54, 2230\u20132238 (2015).","journal-title":"Rheumatology"},{"key":"24279_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura, K. et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of internal medicine 146, 797\u2013808 (2007).","journal-title":"Annals of internal medicine"},{"key":"24279_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10067-005-1104-y","volume":"24","author":"S Kamali","year":"2005","unstructured":"Kamali, S. et al. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjogren\u2019s syndrome, and Wegener\u2019s granulomatosis. Clinical rheumatology 24, 673\u2013676 (2005).","journal-title":"Clinical rheumatology"},{"key":"24279_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejim.2013.07.004","volume":"24","author":"DN O\u2019Dwyer","year":"2013","unstructured":"O\u2019Dwyer, D. N. et al. Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD). European journal of internal medicine 24, 597\u2013603 (2013).","journal-title":"European journal of internal medicine"},{"key":"24279_CR15","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz, T. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62, 1583\u20131591 (2010).","journal-title":"Arthritis Rheum"},{"key":"24279_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel, S. E. & Michaud, K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis research & therapy 11, 229 (2009).","journal-title":"Arthritis research & therapy"},{"key":"24279_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm, O. et al. Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: prevalence, quality of life and mortality\u2013a retrospective study based on registry data. Rheumatology 52, 173\u2013179 (2013).","journal-title":"Rheumatology"},{"key":"24279_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/08916930400022954","volume":"38","author":"F Franceschini","year":"2005","unstructured":"Franceschini, F. & Cavazzana, I. Anti-Ro\/SSA and La\/SSB antibodies. Autoimmunity 38, 55\u201363 (2005).","journal-title":"Autoimmunity"},{"key":"24279_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.rdc.2016.03.005","volume":"42","author":"JM Anaya","year":"2016","unstructured":"Anaya, J. M., Rojas-Villarraga, A., Mantilla, R. D., Arcos-Burgos, M. & Sarmiento-Monroy, J. C. Polyautoimmunity in Sjogren Syndrome. Rheumatic diseases clinics of North America 42, 457\u2013472 (2016).","journal-title":"Rheumatic diseases clinics of North America"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24279-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:23:22Z","timestamp":1671596602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24279-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24279"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24279-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6180"}}